Reported Earnings • May 11
First quarter 2026 earnings released First quarter 2026 results: Revenue: R$214.9m (down 11% from 1Q 2025). Net loss: R$82.2m (loss widened 44% from 1Q 2025). New Risk • Mar 10
New major risk - Revenue and earnings growth Earnings have declined by 1.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-R$19m free cash flow). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-R$2.3b). Earnings have declined by 1.9% per year over the past 5 years. Market cap is less than US$10m (R$41.8m market cap, or US$8.02m). Anuncio • Mar 03
Sansuy S.A., Annual General Meeting, Apr 10, 2026 Sansuy S.A., Annual General Meeting, Apr 10, 2026. Location: rua dos plasticos, 761, area industrial leste, copec, city of camacari, state of bahia, camacari Brazil New Risk • Dec 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Brazilian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-R$59m free cash flow). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Negative equity (-R$2.2b). Market cap is less than US$10m (R$43.7m market cap, or US$8.06m). Reported Earnings • Aug 10
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: R$240.4m (up 5.0% from 2Q 2024). Net loss: R$79.5m (down 216% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Reported Earnings • May 09
First quarter 2025 earnings released First quarter 2025 results: Revenue: R$241.6m (up 9.1% from 1Q 2024). Net loss: R$57.2m (loss widened 49% from 1Q 2024). New Risk • May 09
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -R$28m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-R$28m free cash flow). Negative equity (-R$2.0b). Market cap is less than US$10m (R$51.4m market cap, or US$9.08m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change). Anuncio • Mar 14
Sansuy S.A., Annual General Meeting, Mar 31, 2025 Sansuy S.A., Annual General Meeting, Mar 31, 2025. Location: rua dos plasticos, 761, area, industrial leste, copec, state of bahia., camacari, Brazil Reported Earnings • Mar 04
Full year 2024 earnings released Full year 2024 results: Revenue: R$944.8m (up 6.5% from FY 2023). Net loss: R$22.8m (loss narrowed 83% from FY 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Feb 26
Now 25% undervalued after recent price drop Over the last 90 days, the stock has fallen 13% to R$4.00. The fair value is estimated to be R$5.33, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.8% over the last 3 years. Earnings per share has grown by 4.3%. Buy Or Sell Opportunity • Feb 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to R$4.14. The fair value is estimated to be R$5.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.8% over the last 3 years. Earnings per share has grown by 4.3%. Buy Or Sell Opportunity • Dec 06
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 28% to R$4.15. The fair value is estimated to be R$5.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.8% over the last 3 years. Earnings per share has grown by 4.3%. New Risk • Nov 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Brazilian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Negative equity (-R$2.0b). Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (R$61.0m market cap, or US$10.7m). Reported Earnings • Nov 07
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: R$258.2m (up 10% from 3Q 2023). Net loss: R$47.6m (loss widened 49% from 3Q 2023). New Risk • Oct 17
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: R$55.1m (US$9.73m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-R$1.9b). Earnings have declined by 5.0% per year over the past 5 years. Market cap is less than US$10m (R$55.1m market cap, or US$9.73m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). Reported Earnings • Aug 09
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: R$229.0m (up 3.8% from 2Q 2023). Net income: R$68.8m (up R$89.8m from 2Q 2023). Profit margin: 30% (up from net loss in 2Q 2023). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Reported Earnings • May 12
First quarter 2024 earnings released First quarter 2024 results: Revenue: R$221.5m (up 3.3% from 1Q 2023). Net loss: R$38.5m (loss widened 16% from 1Q 2023). Reported Earnings • Feb 21
Full year 2023 earnings released Full year 2023 results: Revenue: R$886.8m (up 6.4% from FY 2022). Net loss: R$136.1m (loss narrowed 59% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. New Risk • Jan 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Brazilian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-R$1.9b). Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (R$78.1m market cap, or US$15.8m). Reported Earnings • Oct 22
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: R$234.3m (up 3.5% from 3Q 2022). Net loss: R$32.0m (loss narrowed 25% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 02
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: R$220.6m (up 1.8% from 2Q 2022). Net loss: R$21.0m (loss narrowed 49% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 31
Full year 2022 earnings released Full year 2022 results: Revenue: R$833.2m (up 12% from FY 2021). Net loss: R$332.0m (loss widened 194% from FY 2021). Board Change • Feb 17
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • May 15
First quarter 2022 earnings released First quarter 2022 results: Revenue: R$189.3m (up 9.7% from 1Q 2021). Net loss: R$46.5m (loss widened 66% from 1Q 2021). Board Change • Apr 26
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Mar 03
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: R$744.7m (up 46% from FY 2020). Net loss: R$112.8m (loss narrowed 19% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 12
Third quarter 2021 earnings released The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: R$202.1m (up 31% from 3Q 2020). Net loss: R$23.1m (loss narrowed 20% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Mar 29
Full year 2020 earnings released The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: R$511.4m (up 12% from FY 2019). Net loss: R$139.8m (loss narrowed 22% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 92% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 12
New 90-day low: R$5.96 The company is down 13% from its price of R$6.83 on 13 November 2020. The Brazilian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 19% over the same period. Is New 90 Day High Low • Jan 27
New 90-day low: R$5.97 The company is down 11% from its price of R$6.70 on 29 October 2020. The Brazilian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Is New 90 Day High Low • Jan 06
New 90-day low: R$5.98 The company is down 32% from its price of R$8.75 on 08 October 2020. The Brazilian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 19% over the same period. Is New 90 Day High Low • Nov 17
New 90-day low: R$6.25 The company is down 19% from its price of R$7.75 on 19 August 2020. The Brazilian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. Is New 90 Day High Low • Oct 31
New 90-day low: R$6.41 The company is down 3.0% from its price of R$6.59 on 31 July 2020. The Brazilian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 16% over the same period. 
